Elkord E - Search Results

1

Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8⁺ T cells showed synergistic effects on improved disease-free survival in treatment-naïve CRC patients.

Meyiah A, Mahmoodi Chalbatani G, Al-Mterin MA, Malekraeisi MA, Murshed K, Elkord E. Meyiah A, et al. Among authors: elkord e. Int Immunopharmacol. 2023 Jun;119:110207. doi: 10.1016/j.intimp.2023.110207. Epub 2023 Apr 24. Int Immunopharmacol. 2023. PMID: 37099940 Free article.

2

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.

Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, Kitchener HC. Daayana S, et al. Among authors: elkord e. Br J Cancer. 2010 Mar 30;102(7):1129-36. doi: 10.1038/sj.bjc.6605611. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234368 Free PMC article. Clinical Trial.

3

Role of regulatory T cells in allergy: implications for therapeutic strategy.

Elkord E. Elkord E. Inflamm Allergy Drug Targets. 2006 Dec;5(4):211-7. doi: 10.2174/187152806779010945. Inflamm Allergy Drug Targets. 2006. PMID: 17168791 Review.

4

Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.

Ralph C, Elkord E, Burt DJ, O'Dwyer JF, Austin EB, Stern PL, Hawkins RE, Thistlethwaite FC. Ralph C, et al. Among authors: elkord e. Clin Cancer Res. 2010 Mar 1;16(5):1662-72. doi: 10.1158/1078-0432.CCR-09-2870. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179239 Clinical Trial.

5

Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation.

Elkord E. Elkord E. J Immunol Methods. 2009 Aug 15;347(1-2):87-90. doi: 10.1016/j.jim.2009.06.001. Epub 2009 Jun 16. J Immunol Methods. 2009. PMID: 19538964

6

Immune evasion in cancer: Mechanistic basis and therapeutic strategies.

Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS. Vinay DS, et al. Among authors: elkord e. Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198. doi: 10.1016/j.semcancer.2015.03.004. Epub 2015 Mar 25. Semin Cancer Biol. 2015. PMID: 25818339 Free article. Review.

7

T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective.

Shablak A, Hawkins RE, Rothwell DG, Elkord E. Shablak A, et al. Among authors: elkord e. Clin Cancer Res. 2009 Nov 1;15(21):6503-10. doi: 10.1158/1078-0432.CCR-09-1605. Epub 2009 Oct 20. Clin Cancer Res. 2009. PMID: 19843660 Review.

8

Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).

Elkord E, Dangoor A, Burt DJ, Southgate TD, Daayana S, Harrop R, Drijfhout JW, Sherlock D, Hawkins RE, Stern PL. Elkord E, et al. Cancer Immunol Immunother. 2009 Oct;58(10):1657-67. doi: 10.1007/s00262-009-0674-y. Epub 2009 Feb 17. Cancer Immunol Immunother. 2009. PMID: 19221742 Free PMC article.

9

Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.

Elkord E, Williams PE, Kynaston H, Rowbottom AW. Elkord E, et al. Immunology. 2005 Feb;114(2):204-12. doi: 10.1111/j.1365-2567.2004.02076.x. Immunology. 2005. PMID: 15667565 Free PMC article.

10

Helios expression in FoxP3(+) T regulatory cells.

Elkord E, Al-Ramadi BK. Elkord E, et al. Expert Opin Biol Ther. 2012 Nov;12(11):1423-5. doi: 10.1517/14712598.2012.711310. Epub 2012 Jul 25. Expert Opin Biol Ther. 2012. PMID: 22827571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page